Drugs / Alkaline Glucosodiene Molecules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05957939 | Jan → Dec 2024 | triple-negative breast carcinoma | Ministry of Health, Saudi Arabia | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alkaline Glucosodiene Molecules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05957939 ↗ |
| Modality | Small molecule | “small molecules of toxic atoms (alkaline atoms)” NCT05957939 ↗ |